We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+12.82%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$6.37B
AUM Growth
+$1.11B
Cap. Flow
+$527M
Cap. Flow %
8.27%
Top 10 Hldgs %
34.58%
Holding
1,211
New
40
Increased
703
Reduced
424
Closed
39

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$34.5M
2
AAPL icon
Apple
AAPL
+$29.1M
3
BAC icon
Bank of America
BAC
+$21.6M
4
AMZN icon
Amazon
AMZN
+$21M
5
TSLA icon
Tesla
TSLA
+$12.7M

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$6.12M
2
EL icon
Estee Lauder
EL
+$5.61M
3
CARR icon
Carrier Global
CARR
+$5.1M
4
GIS icon
General Mills
GIS
+$4.64M
5
TJX icon
TJX Companies
TJX
+$4.56M

Sector Composition

Rank Sector Weight
1 Technology 32.37%
2 Consumer Discretionary 14.58%
3 Healthcare 11.36%
4 Financials 10.36%
5 Communication Services 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
26
PayPal
PYPL
$52.6B
$37.1M 0.58%
196,652
-11,932
-6% -$2.58M
INTU icon
27
Intuit
INTU
$95.2B
$36.1M 0.57%
56,155
+3,093
+6% +$1.91M
AMD icon
28
Advanced Micro Devices
AMD
$778B
$35.4M 0.56%
246,276
+3,833
+2% +$515K
NKE icon
29
Nike
NKE
$57B
$34.9M 0.55%
209,523
+1,413
+0.7% +$233K
BRK.B icon
30
Berkshire Hathaway Class B
BRK.B
$1.08T
$34.7M 0.54%
115,961
-15,882
-12% -$4.55M
LLY icon
31
Eli Lilly
LLY
$1.05T
$33M 0.52%
119,639
-3,063
-2% -$776K
CRM icon
32
Salesforce
CRM
$206B
$33M 0.52%
129,865
+14,720
+13% +$4.14M
PFE icon
33
Pfizer
PFE
$160B
$30.8M 0.48%
521,138
+105,259
+25% +$5.22M
ABT icon
34
Abbott
ABT
$193B
$28.5M 0.45%
202,734
+24,648
+14% +$3.15M
TMO icon
35
Thermo Fisher Scientific
TMO
$233B
$28.5M 0.45%
42,721
+11,275
+36% +$7.04M
AMAT icon
36
Applied Materials
AMAT
$383B
$28M 0.44%
178,116
-11,863
-6% -$1.72M
AMT icon
37
American Tower
AMT
$81.2B
$27.3M 0.43%
93,419
+6,534
+8% +$1.79M
UPS icon
38
United Parcel Service
UPS
$89.9B
$26.1M 0.41%
121,749
+10,883
+10% +$2.21M
PG icon
39
Procter & Gamble
PG
$333B
$25.6M 0.4%
156,477
-15,037
-9% -$2.23M
ISRG icon
40
Intuitive Surgical
ISRG
$130B
$25.4M 0.4%
70,799
+4,571
+7% +$1.57M
NOW icon
41
ServiceNow
NOW
$143B
$25M 0.39%
192,825
+14,260
+8% +$1.87M
ZTS icon
42
Zoetis
ZTS
$31B
$24.8M 0.39%
101,494
+6,484
+7% +$1.42M
CSCO icon
43
Cisco
CSCO
$442B
$24.8M 0.39%
390,746
+65,127
+20% +$3.72M
XOM icon
44
ExxonMobil
XOM
$643B
$24M 0.38%
392,591
+52,339
+15% +$3.27M
WMT icon
45
Walmart Inc
WMT
$817B
$23.7M 0.37%
491,388
+58,536
+14% +$2.79M
SBUX icon
46
Starbucks
SBUX
$122B
$23.3M 0.37%
199,075
-6,222
-3% -$702K
DHR icon
47
Danaher
DHR
$152B
$23M 0.36%
78,926
+10,407
+15% +$2.87M
MCD icon
48
McDonald's
MCD
$184B
$22.9M 0.36%
85,606
+10,841
+15% +$2.74M
ORCL icon
49
Oracle
ORCL
$438B
$22.9M 0.36%
262,943
+18,330
+7% +$1.72M
AMGN icon
50
Amgen
AMGN
$236B
$22.8M 0.36%
101,332
+8,189
+9% +$1.73M

Similar funds

Xponance's Q4 2021 Portfolio in Review

As of Q4 2021, Xponance held 1,211 positions worth $6.37B, up 21% from $5.27B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Xponance deployed $527M of net new capital in Q4 2021, opening 40 new positions and adding to 703 existing holdings. Its largest new stake was Wolfspeed: 12,874 shares worth $1.44M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Entergy, an estimated $6.12M trimmed.

  • Xponance's largest Q4 2021 buy was Wolfspeed: 12,874 shares worth $1.44M.
  • Xponance added most to Microsoft in Q4 2021, an estimated $34.5M increase.
  • Xponance's biggest Q4 2021 reduction was Entergy, cutting an estimated $6.12M.
  • Xponance fully exited Kansas City Southern in Q4 2021, selling an estimated $1.91M.
  • Xponance's ten largest holdings make up 35% of its $6.37B portfolio in Q4 2021.
  • Xponance opened 40 new positions and closed 39 in Q4 2021.
  • Xponance's portfolio value rose 21% quarter-over-quarter to $6.37B.

Based on Xponance's 13F filing for Q4 2021, filed 31 Jan 2022.